Simultaneous inhibition of FAK and ROS1 synergistically repressed triple-negative breast cancer by upregulating p53 signalling
Abstract Background Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype lacking effective targeted therapies, necessitating innovative treatment approaches. While targeting ROS proto-oncogene 1 (ROS1) with crizotinib has shown promise, resistance remains a limitation. Recent...
Saved in:
Main Authors: | Ximin Tan (Author), Deguang Kong (Author), Zhuoli Tao (Author), Fangling Cheng (Author), Baoyuan Zhang (Author), Zaiqi Wang (Author), Qi Mei (Author), Chuang Chen (Author), Kongming Wu (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TNFAIP8 Promotes Cisplatin Chemoresistance in Triple-Negative Breast Cancer by Repressing p53-Mediated miR-205-5p Expression
by: Hong-Yu Ma, et al.
Published: (2020) -
Indoxyl sulfate upregulates renal expression of icam-1 via production of ros and activation of nf-κb and p53 in proximal tubular cells
by: Hidehisa Shimizu, et al.
Published: (2012) -
Atovaquone Suppresses the Growth of Metastatic Triple-Negative Breast Tumors in Lungs and Brain by Inhibiting Integrin/FAK Signaling Axis
by: Nehal Gupta, et al.
Published: (2021) -
Nrf2 Inhibits the Progression of Parkinson’s Disease by Upregulating AABR07032261.5 to Repress Pyroptosis
by: Zhong Y, et al.
Published: (2022) -
De-repressing LncRNA-Targeted Genes to Upregulate Gene Expression: Focus on Small Molecule Therapeutics
by: Roya Pedram Fatemi, et al.
Published: (2014)